Oral & Sublingual
Tablet, capsule, or sublingual delivery — limited to peptides with demonstrated oral bioactivity.
Overview
Oral administration involves swallowing a peptide in solution, capsule, or tablet form where it passes through the gastrointestinal tract. The challenge is that most peptides are proteolytic substrates — they are cleaved by digestive enzymes (pepsin, trypsin, chymotrypsin) and hydrolysed by gastric acid before reaching the circulation. Sublingual delivery, where the compound is held under the tongue and absorbed through the thin oral mucosa, bypasses the GI tract and offers meaningfully better bioavailability for select compounds. Only a narrow category of peptides has demonstrated clinically relevant oral or sublingual activity.
Equipment Required
Administration Sites
Administration Protocol
Do not eat or drink for at least 15 minutes before sublingual administration. Food and saliva production dilute and mechanically clear the compound before absorption occurs.
Draw the prescribed volume of reconstituted peptide solution into an oral syringe or dropper. For capsule-based oral protocols, prepare the capsule as directed.
Sit upright or stand. Lift the tongue to expose the sublingual mucosa — the tissue beneath the tongue is thin, moist, and highly vascular.
Place the syringe tip under the tongue and deposit the solution slowly. Avoid forceful squirting — the goal is contact with the mucosa, not movement to the back of the throat.
Keep the solution pooled under the tongue for 60–90 seconds. Minimise tongue movement and saliva production. Do not swallow during this period.
After the hold period, swallow the remaining solution. While most of what reaches the stomach will be degraded, some oral-active peptides (e.g. BPC-157 in research) may retain partial activity via enteric absorption.
Avoid eating or drinking for a further 10–15 minutes to allow residual mucosal absorption to complete.
✅ Best Practices
- BPC-157 is the most researched oral peptide — studies suggest partial GI-mediated activity even when swallowed, making it suitable for gut-targeted applications.
- KPV has demonstrated oral activity in IBD and gut inflammation models and is specifically researched via the oral route.
- Peptide doses for oral administration are typically 5–10× higher than injected equivalents to compensate for absorption losses.
- Sublingual preparations should be stored refrigerated and used within the same reconstitution window as injectable solutions.
⚠️ Common Mistakes
- Expecting injectable efficacy from oral administration of peptides with no oral bioavailability data.
- Swallowing immediately after placing under the tongue — eliminates the sublingual absorption window entirely.
- Using oral for large or complex peptides (TB-500, CJC-1295, semaglutide analogue) — these are entirely degraded before absorption.
- Reconstituting in acidic or non-sterile diluents — degrades the compound before it reaches the absorption site.
Commonly Used With
Frequently Asked Questions
Why do most peptides fail when taken orally?
Peptides are polymer chains of amino acids — the very structures that digestive enzymes are designed to break down. Gastric acid and proteases (pepsin, trypsin) cleave peptide bonds efficiently. Only peptides with unusual stability (cyclic structure, D-amino acid substitutions, or demonstrated GI resistance) retain meaningful bioactivity after oral transit.
Does BPC-157 really work when swallowed?
Research evidence in animal models suggests BPC-157 retains some biological activity when administered orally, particularly for gut-related endpoints (ulcer healing, colitis models). The mechanism is not fully understood — partial absorption through the intestinal epithelium and local GI effects both likely contribute.
What is the difference between oral and sublingual for peptides?
Sublingual delivery bypasses the GI tract entirely by absorbing through the oral mucosa directly into the bloodstream. It is faster, avoids gastric degradation, and produces higher plasma concentrations than swallowing for the same dose. However, only compounds that can penetrate the oral mucosa effectively benefit from this route.
Can I mix a peptide with food or a drink for oral dosing?
Not recommended. Food and beverages alter gastric pH, add competing substrates for digestive enzymes, and delay gastric emptying — all of which can reduce the already-limited bioavailability of an orally-administered peptide. Oral peptide doses should be taken on an empty stomach in a small volume of water.
Explore all administration routes
All Application Methods →